RecruitingNCT06470607

The Lymphocytic Infiltrate of Lung Tumors.

Biological Observational Monocentric Study Aimed at Analyzing the Lymphocytic Infiltrate of Lung Tumors

Sponsor

Scientific Institute San Raffaele

Enrollment

70 participants

Start Date

Jan 20, 2023

Study Type

OBSERVATIONAL

Conditions

Lung Cancer Immune System

Summary

The study is configured as a monocentric observational transversal biological study. The main objective of the study is the reconstruction of the molecular organization of tumors of the thoracic cavity, in particular non-small cell lung cancer (NSCLC). The study involves the collection of clinical data and biological material (blood and tumor tissue) from 70 subjects diagnosed with thoracic tumors.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is examining the immune cells (specifically lymphocytes, which are white blood cells) that are found within and around lung tumors in patients undergoing surgery. Understanding these immune profiles may help predict outcomes and guide future treatments. **You may be eligible if...** - You are 18 or older - You are scheduled for surgery to treat a suspected or confirmed chest (thoracic) tumor - You are able to give informed consent **You may NOT be eligible if...** - You have received chemotherapy for any cancer in the past 6 months - You are pregnant or breastfeeding - You are in an immunosuppressed state or are taking immunosuppressive drugs Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.